Generation of reference genomes for Trypanosoma cruzi using PacBio sequencing
Generation of reference genomes for Trypanosoma cruzi using PacBio sequencing
批准号:
9251753
负责人:
Rick L Tarleton
金额:
$7.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2019-03-31
关键词:
AddressAmericasBiological PhenomenaBloodCellsChagas DiseaseChromosomesCommunitiesComplexConsensusDataDideoxy Chain Termination DNA SequencingDiploidyEpidemiologyEtiologyEvolutionFutureGene DuplicationGene FamilyGenerationsGenesGeneticGenomeGenome MappingsGenomic DNAGenomicsGoalsGrantHeterozygoteHybridsImmune EvasionInstitutesIonsKaryotypeLaboratoriesLengthLibrariesMaintenanceManualsMapsMembrane ProteinsModificationMolecular WeightMosaicismNatureOutcomePPBP geneParasitesPharmacotherapyPreventionProtonsStructureTechnologyTestingTrypanosoma cruziValidationbaseduplicate genesgenome sequencinggenome-widehuman diseaseimprovedinterestnext generation sequencingprogramspublic health relevancereference genomesingle moleculevirtualwhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The most persistent and significant hindrance to genomic studies of Trypanosoma cruzi is the lack of an acceptable reference genome. There are a number of factors that have impeded progress in generating a high quality, fully assembled T. cruzi reference sequence, including high repeat content (50%) in the T. cruzi genome, extreme genome-wide heterozygosity in the reference strain (CL-Brener) that was chosen for sequencing and reference genome assembly, and genetic mosaicism in the reference strain. Thus, the current reference genome for T. cruzi has hundreds of gaps and regions of assembly collapse, has never been fully assembled and is, in fact, presented as two genomes due to the heterozygosity of the reference strain -each chromosome is presented as two versions differing substantially in terms of gene content, sequence identity where the two chromosome sequences align, and even lengths of the two chromosomes in a pair. These issues have greatly muted the efficacy and power of previous and ongoing whole genome sequencing studies in this causative agent of human disease, and have made virtually any endeavor involving the need for scrutinizing the reference genome difficult and frequently unproductive. We propose to tackle the issues with the current T. cruzi reference genome using three modifications of the approach originally used to generate it. First, we propose to use single-molecule, long-read (up to 10 kb) sequencing to close gaps and expand regions of assembly collapse that occurred when primarily Sanger reads (700 bp) were used to assemble the original CL-Brener reference genome. Second, we will select T. cruzi isolates for sequencing that are homozygous and do not have mosaic genomes to simplify the assemblies. Third, because all T. cruzi lines are derived from two ancestral, divergent, homozygous, non-mosaic lineages, we will generate reference sequences to each "parental" lineage in order to cover the scope of genetic content in all T. cruzi isolates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The activation of benzoxaborole prodrug AN15368, a clinical candidate for Chagas disease
-
批准号:10667721
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2023
-
负责人:Rick L Tarleton
-
依托单位:
Optimizing blood PCR as test of cure in Chagas disease
-
批准号:10451977
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2022
-
负责人:Rick L Tarleton
-
依托单位:
Optimizing blood PCR as test of cure in Chagas disease
-
批准号:10590740
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2022
-
负责人:Rick L Tarleton
-
依托单位:
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
-
批准号:10573204
-
项目类别:
-
资助金额:$47.7万
-
财政年份:2020
-
负责人:Rick L Tarleton
-
依托单位:
Trypanosoma cruzi dormancy and its implications for therapeutic treatment
-
批准号:10368984
-
项目类别:
-
资助金额:$47.7万
-
财政年份:2020
-
负责人:Rick L Tarleton
-
依托单位:
Purchase of an imaging flow cytometer 2016
-
批准号:9273704
-
项目类别:
-
资助金额:$45.38万
-
财政年份:2017
-
负责人:Rick L Tarleton
-
依托单位:
Mechanisms of persistence in Trypanosoma cruzi infection
-
批准号:9754759
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Multiplex treatment outcomes test for Chagas disease
-
批准号:9305839
-
项目类别:
-
资助金额:$100.08万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Mechanisms of persistence in Trypanosoma cruzi infection
-
批准号:9237877
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Mechanisms of persistence in Trypanosoma cruzi infection
-
批准号:9979735
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Development of CRISPR/Cas system for study of trans-sialidase family genes in T. cruzi
-
批准号:9054467
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2016
-
负责人:Rick L Tarleton
-
依托单位:
Making benznidazole a better drug for Chagas disease
-
批准号:8652132
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2014
-
负责人:Rick L Tarleton
-
依托单位:
Making benznidazole a better drug for Chagas disease
-
批准号:8903699
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:Rick L Tarleton
-
依托单位:
Transmission-blocking live vaccine for Chagas disease
-
批准号:8968183
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2011
-
负责人:Rick L Tarleton
-
依托单位:
Transmission-blocking live vaccine for Chagas disease
-
批准号:8585810
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2011
-
负责人:Rick L Tarleton
-
依托单位:
Transmission-blocking live vaccine for Chagas disease
-
批准号:8390470
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2011
-
负责人:Rick L Tarleton
-
依托单位:
Transmission-blocking live vaccine for Chagas disease
-
批准号:8237761
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2011
-
负责人:Rick L Tarleton
-
依托单位:
Multi-color Flow Analyzer for the UGA-CTEGD Flow Facility
-
批准号:7794363
-
项目类别:
-
资助金额:$34.79万
-
财政年份:2010
-
负责人:Rick L Tarleton
-
依托单位:
Multiplex serodiagnostic test for Chagas disease
-
批准号:8103493
-
项目类别:
-
资助金额:$78.25万
-
财政年份:2010
-
负责人:Rick L Tarleton
-
依托单位:
Drug Discovery Consortium for Chagas Disease
-
批准号:7656093
-
项目类别:
-
资助金额:$113.77万
-
财政年份:2009
-
负责人:Rick L Tarleton
-
依托单位:
海外基金